**Conclusion.** The lead's results replicate exactly. All five specifications, run independently from `ivdoctr::colonial` (64 countries) via `AER::ivreg`, match the robustness table to every reported digit — OLS, 2SLS, first-stage coefficient, sample size, and F statistic. The memo's interpretive stance is sound: it neither treats the weak-F rows as confirmation nor as refutation, which is exactly right. No corrections needed.

**Numeric cross-check** (my independent run; lead's values identical):

| Spec | N | OLS | 2SLS | FS `logem4` | Partial F |
|:--|--:|--:|--:|--:|--:|
| Baseline | 64 | 0.522 | 0.944 | −0.607 | 22.95 |
| + Latitude | 64 | 0.468 | 0.996 | −0.510 | 13.09 |
| + Continent | 64 | 0.434 | 0.839 | −0.533 | 11.01 |
| Drop neo-Europes | 60 | 0.487 | 1.281 | −0.391 | 8.65 |
| Africa only | 27 | 0.302 | 2.400 | −0.108 | 0.30 |

Path and F definition: 2SLS via `AER::ivreg`; F is the ordinary homoskedastic partial F on the excluded `logem4`, computed as `anova()` of nested first-stage `lm` models on the identical complete-case rows used by OLS and IV within each spec. With one excluded instrument, F equals the squared first-stage t (verified, e.g. 4.790² = 22.95). All 64 rows are complete on `logpgp95`, `avexpr`, `logem4`, `lat_abst`, `africa`, `asia`, so no sample drift enters across specs 1–3; I confirmed the neo-Europe drop by `shortnam` yields n = 60 and Africa-only yields n = 27.

**Interpretation guidance — checklist for the final memo:**

1. *F < 10 is a precision screen, not a validity verdict.* The neo-Europe row (F = 8.65) is marginal, not collapsed; its 2SLS estimate (1.281) is imprecise, not disproven. Only the Africa-only row (F = 0.30) reflects genuine loss of identification. The memo's current language respects this distinction.
2. *Africa-only: loss of identification, not evidence of heterogeneity.* With F = 0.30 the 2SLS estimate of 2.400 (SE ≈ 3.99) is uninformative in both directions. The memo correctly says this "cannot establish an Africa-specific effect or cross-region heterogeneity" — it should equally avoid implying the mechanism *fails* in Africa. The within-Africa mortality variation is simply too weakly related to `avexpr` to test anything.
3. *Do not let the F > 10 rows carry causal weight alone.* The threshold screens for weak-instrument bias, not exclusion. Exact identification means no overID test exists; the memo already states this.
4. *One subtlety worth a clause, not a rewrite:* the continent-controls F of 11.01 sits close enough to 10 that under stricter modern thresholds (e.g. Lee et al.'s tF, or Stock–Yogo size-distortion critical values around 16.4) even the "surviving" specs 2–3 would warrant wider effective confidence intervals. The memo's "not uniformly precise" sentence gestures at this; it is defensible as written.

**Checks performed:** all five specs re-estimated independently; identical-row constraint verified within each spec; restricted vs. unrestricted first stage compared by nested ANOVA; F = t² identity confirmed; neo-Europe drop cross-checked against n; lead's table and memo read and compared line by line.

**Residual risk:** low. The only exposure is threshold conventionality — the F > 10 rows pass the rule-of-thumb screen the brief specifies but not stricter modern weak-IV criteria; a hostile referee could press on specs 2–3. The homoskedastic F is what the brief asked for, but a robust (heteroskedasticity-consistent) effective F would be lower and is the one caveat neither document mentions.
